⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30140932 | 1.00 | — | — | |
| SCHEMBL13549 | 0.81 | — | — | |
| Benzo[D]Isoxazole SCHEMBL29366929 | 0.70 | — | — | |
| Benzo[D]Isoxazole SCHEMBL1355530 | 0.70 | — | — | |
| Benzo[D]Isoxazole SCHEMBL8438 | 0.70 | — | — | |
| Benzo[D]Isoxazole SCHEMBL5778868 | 0.68 | TDO2 (0.34) | — | |
| Benzo[D]Isoxazole SCHEMBL28482344 | 0.68 | TDO2 (0.39) | — | |
| Benzo[D]Isoxazole SCHEMBL29184280 | 0.68 | TDO2 (0.34) | — | |
| Benzo[D]Isoxazole SCHEMBL21596877 | 0.68 | TDO2 (0.34) | — | |
| Benzo[D]Isoxazole SCHEMBL5158032 | 0.68 | TDO2 (0.34) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 505 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2376079-B1 | METHODS OF USING SUBSTITUTED ISOXAZOLO PYRIDINONES AS DISSOCIATED GLUCOCORTICOIDS | VAN ANDEL RES INST (US) | 2016-08-10 | — | — | EP | claimed |
| US-8173670-B2 | Methods of using substituted isoxazolo pyridinones as dissociated glucocorticoids | VAN ANDEL RESEARCH INSTITUTE (US) | 2012-05-08 | — | — | US | claimed |
| EP-2376079-A1 | METHODS OF USING SUBSTITUTED ISOXAZOLO PYRIDINONES AS DISSOCIATED GLUCOCORTICOIDS | Van Andel Research Institute (US) | 2011-10-19 | — | — | EP | claimed |
| US-20110251211-A9 | METHODS OF USING SUBSTITUTED ISOXAZOLO PYRIDINONES AS DISSOCIATED GLUCOCORTICOIDS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2011-10-13 | — | — | US | claimed |
| WO-2010083218-A1 | METHODS OF USING SUBSTITUTED ISOXAZOLO PYRIDINONES AS DISSOCIATED GLUCOCORTICOIDS | VAN ANDEL RESEARCH INSTITUTE (US) | 2010-07-22 | — | — | WO | claimed |
| US-20100179167-A1 | METHODS OF USING SUBSTITUTED ISOXAZOLO PYRIDINONES AS DISSOCIATED GLUCOCORTICOIDS | VAN ANDEL RESEARCH INSTITUTE | 2010-07-15 | — | — | US | claimed |
| US-7122547-B1 | Anthranilic acid amides and the use thereof as medicaments | SCHERING AG (DE) | 2006-10-17 | — | — | US | claimed |
| EP-1568368-A1 | Pharmaceutical combination comprising a CDK inhibitor and a VEGF receptor inhibitor | SCHERING AKTIENGESELLSCHAFT (DE) | 2005-08-31 | — | — | EP | claimed |
| EP-1129074-A2 | ANTRHRANILIC ACID AMIDES AND THE USE THEREOF AS MEDICAMENTS | SCHERING AKTIENGESELLSCHAFT (DE) | 2001-09-05 | — | — | EP | claimed |
| WO-2000027819-A2 | ANTRHRANILIC ACID AMIDES AND THE USE THEREOF AS MEDICAMENTS | SCHERING AKTIENGESELLSCHAFT (DE) | 2000-05-18 | — | — | WO | claimed |
| US-20260124177-A1 | CO-THERAPIES INCLUDING A METASTASIS INHIBITOR | NOVITA PHARMACEUTICALS, INC. (US) | 2026-05-07 | — | — | US | disclosed |
| EP-4735420-A1 | ARYL INDOL-3-YL KETONE AND ARYL INDAZOL-3-YL KETONE INHIBITORS OF KIF18A | Volastra Therapeutics, Inc. (US) | 2026-05-06 | — | — | EP | disclosed |
| EP-4727548-A1 | METHOD OF TREATING CANCER WITH INDOLINE INHIBITORS OF KIF18A | Volastra Therapeutics, Inc. (US) | 2026-04-22 | — | — | EP | disclosed |
| US-20260098018-A1 | BICYCLIC 1,4-DIAZEPANONES AND THERAPEUTIC USES THEREOF | CYTOKINETICS INC (US) | 2026-04-09 | — | — | US | disclosed |
| US-12534471-B2 | Pyrrolo[1, 2-c]imidazole derivatives as orexin type 2 receptor agonists and methods of use thereof | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2026-01-27 | — | — | US | disclosed |
| EP-1275301-A1 | Trisubstituted heterocyclic compounds and their use as fungicides | Bayer CropScience S.A. (FR) | 2003-01-15 | — | — | EP | disclosed |
| EP-1129074-A2 | ANTRHRANILIC ACID AMIDES AND THE USE THEREOF AS MEDICAMENTS | SCHERING AKTIENGESELLSCHAFT (DE) | 2001-09-05 | — | — | EP | disclosed |
| WO-2000027819-A2 | ANTRHRANILIC ACID AMIDES AND THE USE THEREOF AS MEDICAMENTS | SCHERING AKTIENGESELLSCHAFT (DE) | 2000-05-18 | — | — | WO | disclosed |
| EP-0835242-A1 | THIOAMIDES S-OXIDES FOR USE AS PESTICIDES | Novartis AG (CH) | 1998-04-15 | — | — | EP | disclosed |
| WO-1997000859-A1 | THIOAMIDES S-OXIDES FOR USE AS PESTICIDES | NOVARTIS AG (CH) | 1997-01-09 | — | — | WO | disclosed |